Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Prevention of post-operative nausea and vomiting (PONV) in 'day surgery patients'; Granisetron v/s Placebo, Cyclizine and Ondansetron.
ISRCTN ISRCTN07711014
ClinicalTrials.gov identifier
Public title Prevention of post-operative nausea and vomiting (PONV) in 'day surgery patients'; Granisetron v/s Placebo, Cyclizine and Ondansetron.
Scientific title
Acronym N/A
Serial number at source N0084144579
Study hypothesis To compare the effectiveness of granisetrone with ondansetrone, cyclizine and placebo in the prevention of post-operative nausea and vomiting in patients undergoing "Day Surgery" under general anaesthesia.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Signs and Symptoms: Post operative nausea and vomiting (PONV)
Participants - inclusion criteria Not provided at time of registration
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/09/2003
Anticipated end date 01/09/2004
Status of trial Completed
Patient information material
Target number of participants It is anticipated to recruit 4 groups of 30 patients each = total of 120 patients into this study.
Interventions Patients are to continue to have general anaesthesia for their surgical procedure. Every participating patient to receive a prophylactic anti emetic, randomly selected, at the beginning of anaesthetic induction.

Anti emetics to be divided into 4 groups:
A: Cyclizine 50mgm I.V.
B: Ondansetrone 4mgm I.V.
C: Granisetrone 1mgm I.V
D: Placebo.
Primary outcome measure(s) Post operative record of patients PONV status to be recorded by the nurse in PACU (Post anaesthetic care unit). Rescu anti-emetic to be given by the nurse in PACU as per protocol. Emesis score as follows: 0 - None; 1 - Nausea; 2 - Retching; 3 - Vomiting. Patient to complete the simple questionnaire regarding her post operative recovery and return by pre-paid envelope the next day.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Northern Lincolnshire and Goole Hospitals NHS Trust (UK), NHS R&D Support Funding
Trial website
Publications
Contact name Dr  Bhaskar  Tandon
  Address Northern Lincolnshire & Goole Hospitals NHS Trust
Diana Princess of Wales Hospital
Scartho Road
  City/town Grimsby
  Zip/Postcode DN33 2BA
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 21/04/2011
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central